| Literature DB >> 33498634 |
Sadegheh Haghshenas1,2, Michael A Levy2, Jennifer Kerkhof2, Erfan Aref-Eshghi3, Haley McConkey2, Tugce Balci4,5, Victoria Mok Siu5, Cindy D Skinner6, Roger E Stevenson6, Bekim Sadikovic1,2, Charles Schwartz6.
Abstract
A growing number of genetic neurodevelopmental disorders are known to be associated with unique genomic DNA methylation patterns, called episignatures, which are detectable in peripheral blood. The intellectual developmental disorder, X-linked, syndromic, Armfield type (MRXSA) is caused by missense variants in FAM50A. Functional studies revealed the pathogenesis to be a spliceosomopathy that is characterized by atypical mRNA processing during development. In this study, we assessed the peripheral blood specimens in a cohort of individuals with MRXSA and detected a unique and highly specific DNA methylation episignature associated with this disorder. We used this episignature to construct a support vector machine model capable of sensitive and specific identification of individuals with pathogenic variants in FAM50A. This study contributes to the expanding number of genetic neurodevelopmental disorders with defined DNA methylation episignatures, provides an additional understanding of the associated molecular mechanisms, and further enhances our ability to diagnose patients with rare disorders.Entities:
Keywords: Armfield X-linked intellectual disability; DNA methylation; FAM50A; constitutional disorders; epigenetics; episignature
Year: 2021 PMID: 33498634 PMCID: PMC7865843 DOI: 10.3390/ijms22031111
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923